Meet our partners for Animal Health, Nutrition & Technology Innovation Asia
If you're keen to join them and want to learn more about participation opportunities, download the 2024 Partnership Brochure here
Platinum Partners
ZENOAQ
Website: https://www.zenoaq.com/en/
ZENOAQ is dedicated to fostering a lasting and meaningful future for both humans and animals. As part of our commitment to advancing drug development, veterinary therapy, and biotechnology, we aim to enhance the value of animals. Our core activities are closely aligned with the needs of our clients, positively impacting their animals in various ways. This network extends beyond Japan, reaching across international borders to create mutual benefits for humans and animals alike.
Zoetis
Website: https://www.zoetis.com/
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees.
For more information, visit www.zoetis.com
Associate Partners
Elanco
Website: www.elanco.com
Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet.
Senior Event Partners
AstraSana
Website: https://astrasana-animal-health.com/en/
AstraSana Animal Health is a Swiss company specialising in the development and production of innovative cannabinoid products for animals. The focus lies on a holistic and natural approach to enhance animal health. The company is the 1st worldwide to offer authorised CBD products for cats, dogs and horses in the EU. Thanks to collaboration with experts in veterinary medicine, chemistry, biology and leading universities, the products are guaranteed to be highly effective and safe. New products continuously are being developed to improve the well-being of animals. AstraSana Animal Health stands for natural, holistic products without side effects, combined with expertise and passion for animals.
Meiji Animal Health
Website: https://www.vet.meiji.com/global/
Meiji Animal Health Co., Ltd. was established in April 2022 under the umbrella of Meiji Holdings Co., Ltd. and specializes in the research, development, and marketing of veterinary pharmaceuticals. With a One Health approach in mind, we aim to improve both human and animal health through our business, and are particularly tackling zoonoses and emerging and re-emerging infectious animal diseases. In addition, we have established the AMR Surveillance Laboratory in collaboration with Azabu University, an educational institution, to raise awareness of the proper use of antimicrobial agents in animal clinical settings, and we also actively participate in AMR countermeasures by providing AMR survey results to government agencies. Our research and development technology, experience in introducing overseas products to Japan, and promotional expertise in Japan have attracted considerable attention from overseas manufacturers, government agencies, and start-up companies in the same industry. We are doing business in several countries outside of Japan, and we are in advanced discussions with a number of potential partners for business cooperation in Japan and around the world. We aim to be a link between Asia and the world by aggressively expanding overseas and providing internationally recognized value
Event Partners
AB7 Sante
Website: https://www.ab7group.com/en/home
AB7 Santé is a French Veterinary Pharmaceutical Laboratory that has been innovating for over 50 years in the field of Animal Health.
Fully integrated for better agility, AB7 is specialized in research, development, production, quality control, registration and sales of veterinary medicines, generics, OTC, biocides & pet care products for the global market.
With its industrial know-how over 2 certified units in France (GMP) and in the United States (EPA), AB7 is able to address specific manufacturing needs, from small series to large volumes, by ensuring a high level of quality and offering the capacity to adapt manufacturing resources, method and technology.
As a CDMO Company, we offer our partners pharmaceutical and non-pharmaceutical outsourcing activities from development to manufacturing by integrating an innovative, sustainable and responsible approach.
AB7 has continually invested in R&D and production capacities with a constant desire to develop its industrial know-how and to own state-of-the-art equipment for a relevant service in the field of pharmaceutical products within GMP standards. Our 5 R&D Laboratories with more than 45 specialists and our industrial equipments allow us to satisfy the requirements of both small and large pharmaceutical companies within a constructive partnership.
Specialized in exclusive drug delivery systems, AB7 supports its partners in the development of new innovative products and is able to provide full line of products with more traditional galenics.
At AB7, we aim to contribute to today's animal health and welfare challenges by working with international partners to achieve this mission together.
Clinglobal
Website: https://www.clinglobal.com/
Clinglobal is a global, science-based, quality-driven group dedicated to accelerating innovation by providing services and solutions to the animal care industry through the ever-expanding Clinglobal group of companies. Animals are our passion, and people are our strength. Together, we better lives by accelerating animal health innovation.
Our unique business model allows the animal health industry and community to benefit from simplified, comprehensive, and customisable contracting solutions for animal health and nutrition product development and registration.
Our group include companies such as Clinvet (preclinical and lab clinical studies in companion and production animals), Clindata (data management and statistical analysis solutions), Clinomics (molecular biology, clinical pathology and immunology R&D laboratory), rtilab (microbiology and clinical pathology R&D laboratory) and Clinglobal (product development consultancy, regulatory affairs and quality assurance services), as well as an extensive network of strategic partners across geographies and fields of expertise.
Reber Genetics
Website: https://en.reber.com.tw/
Reber Genetics was founded in 2008 with the objective of becoming a successful biotechnology company devoted to innovative R&D and high-quality products. The mission of Reber Genetics is to deliver preventative health care in animals. To achieve that, we concentrate on development of new generation biotechnologies to benefit farmers, promote the prosperity of livestock farming, and contribute to the goal of ONE HEALTH. Now we are expanding the product pipeline and aim to bring these innovative vaccine products like subunit vaccines, DNA vaccines, antibody drugs and customized therapeutic protein onto the global markets. We are proud to be the frontrunner in applying state of the art technologies to animal vaccines and we are confident in our ability to create the best solutions for our customers.
2024 Partnership Opportunities
Check out the official 2024 Partnership Brochure to discover the content focus, new features, audience breakdown and the opportunities available to you.
